← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2013Last known activity
Aug 1, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (12 distinct, 6 trials)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
Recent trials (17)
- NCT05695664Lead sponsorEarly Phase 1Aug 1, 2021
- NCT05695664Reponsible party - principal investigatorEarly Phase 1Aug 1, 2021
- NCT04692623Study chairPhase 1Mar 1, 2021
- NCT06790615Sponsor investigatorPhase 1/Phase 2Jun 1, 2020
- NCT06790615Lead sponsorPhase 1/Phase 2Jun 1, 2020
- NCT02169856Reponsible party - principal investigatorN/AJul 1, 2013
- NCT02169856Study chairN/AJul 1, 2013
- NCT02169856Lead sponsorN/AJul 1, 2013
- NCT02169856Overall official - principal investigatorN/AJul 1, 2013
- NCT02162134Study chairN/AJan 1, 2013
- NCT02162134Lead sponsorN/AJan 1, 2013
- NCT02212392Lead sponsorPhase 1/Phase 2Jan 1, 2013
- NCT02162134Overall official - principal investigatorN/AJan 1, 2013
- NCT02212392Overall official - principal investigatorPhase 1/Phase 2Jan 1, 2013
- NCT02212392Study chairPhase 1/Phase 2Jan 1, 2013
Details
- Last known activity
- Aug 1, 2021